Nanobodies, the single-domain antibody fragments originally derived from camelids, have become indispensable instruments across modern biology. Because they are compact, remarkably stable, and easy to engineer, they serve as conformational stabilizers, crystallization chaperones, biosensors, intracellular targeting agents, and imaging probes. Clinically, the class has already produced approved drugs such as caplacizumab, and nanobody-based therapeutics are advancing against cancer, autoimmune disorders, and infectious disease. In structural biology, their most celebrated role has been locking fragile membrane proteins into defined functional states, a strategy that made high-resolution structures of G-protein-coupled receptors possible more than a decade ago.

Traditionally, these binders are obtained by immunizing llamas or other animals with the protein of interest, an approach that fails when antigens are toxic, unstable, or require trapping in artificial conditions such as extreme pH or fully liganded states. Synthetic libraries sidestep these constraints entirely. Instead of an immune system, researchers use combinatorial gene libraries encoding billions of randomized antibody fragments, then select binders in vitro. Among the display technologies available, ribosome display is uniquely powerful because it couples each protein to its encoding messenger RNA without any cells, allowing theoretical diversities of 10^12 to 10^13 to be explored in a test tube, far beyond what phage or yeast display can practically achieve.

The existing benchmark, the Seeger concave sybody library, has enabled countless selections, including binders that trap membrane proteins in specific conformations. However, it carries a hidden incompatibility. Its nanobody constructs lack the C-terminal histidine tag that the Legobody system requires to recognize its target. Legobody, an approximately 120-kilodalton scaffold assembled from a sybody, an engineered maltose-binding protein, and a nanobody-binding antibody fragment, dramatically enlarges small protein complexes so that cryo-EM image alignment becomes feasible. Without the tag, every sybody recovered from the established libraries must be subcloned and re-engineered before it can be used, adding days of work and eroding throughput precisely where speed matters most.

The new S1.0 library eliminates that detour by embedding the required C-terminal histidine tag and a short Legobody-compatible linker directly into the library scaffold. But the redesign went beyond a simple tagging exercise. Drawing on structural analyses of published concave sybody-antigen complexes, the team noticed that these synthetic binders engage their targets mainly through the CDR1 and CDR2 loops, unlike natural nanobodies, which typically lean heavily on CDR3. In the concave library, the short seven-residue CDR3 and the largely fixed CDR1 had constrained where binding could occur. The researchers therefore extended CDR3 by one residue, raised the number of randomized positions in CDR3 and CDR1 to seven each, and deliberately reduced variability at one CDR2 position, restricting it to serine, tyrosine, arginine, and glutamate to tune surface chemistry while preserving the concave paratope architecture.

The mathematics of library design dictated careful restraint. Nineteen fully randomized positions would imply a theoretical diversity of roughly 5.2 × 10^24, unreachable by any physical display system. Instead, the team employed semi-randomization, enriching bulky aromatic and charged residues at positions likely to contact antigen while weighting choices according to amino-acid frequencies observed in natural nanobody interfaces, yielding a practical theoretical diversity of 10^18. The gene library itself was assembled through overlapping polymerase chain reactions, Type IIS restriction digestion, and T4 ligation, then transcribed into messenger RNA and stored in aliquots at minus 80 degrees Celsius.

Quality control came from deep sequencing. Approximately 9 × 10^7 reads of the naive library revealed that 98 percent of sequences were unique, and most designed amino-acid compositions at randomized positions matched expectations closely, particularly in CDR1, where 23 of 32 compositions showed discrepancies below 10 percent. Some positions, especially in CDR3, deviated more substantially, a caveat the authors acknowledge, though the overall fidelity confirmed that the construction strategy had faithfully captured the intended chemical space.

Functional validation proceeded against two test proteins. In head-to-head selections against calmodulin, performed in parallel with the benchmark concave library, S1.0 produced 45 positive clones from 96 screened, compared with 61 for the established library, but the S1.0 binders showed statistically significantly stronger calcium-dependent ELISA signals. Selections against thermostable green fluorescent protein, enzymatically biotinylated for magnetic bead capture, were even more striking: after one round of ribosome display and two rounds of phage display with off-rate selection, an enrichment factor of 427 was recorded, and ten unique sybody sequences emerged from twelve colonies analyzed. Fluorescence-detection size-exclusion chromatography showed that all ten shifted the elution profile of the fluorescent target, and biolayer interferometry confirmed nanomolar binding, with the best binder, named SH2, achieving a dissociation constant of 1.9 nanomolar.

The decisive experiment came next. When sybodies SH1 and SH2 were mixed with TGP and Legobody components, both assembled into stable complexes that could be pulled down through the maltose-binding protein’s affinity for amylose resin, detected directly by gel electrophoresis with no re-engineering of any kind. That intrinsic compatibility transforms the workflow for structural studies: a selection campaign that once ended with weeks of subcloning can now feed binders straight into Legobody assembly and cryo-EM grid preparation.

The authors are candid about remaining limitations. Validation covered only two soluble targets, and performance against the small membrane proteins that motivate the entire endeavor remains to be demonstrated. Sequencing also revealed instructive surprises, such as the strong underrepresentation of isoleucine at position 29 among functional binders despite its 20 percent abundance in the design, evidence that effective functional diversity, not raw theoretical diversity, ultimately governs library success. The team argues that accumulating sequencing data from naive and enriched libraries, mined with machine-learning approaches and shared through public repositories, should guide the next generation of synthetic nanobody libraries, turning empirical selection outcomes into ever-smarter designs.

Subject of Research: Design and validation of a ribosome display library for synthetic nanobody selection

Article Title: Design and validation of a ribosome display library for synthetic nanobody selection

Article References: Design and validation of a ribosome display library for synthetic nanobody selection. (n.d.). https://doi.org/10.1007/s44307-026-00112-z

Image Credits: AI Generated

DOI: 10.1007/s44307-026-00112-z

Keywords: nanobodies, sybodies, ribosome display, synthetic antibody library, Legobody, cryo-EM, structural biology, membrane proteins, CDR randomization, biolayer interferometry, phage display, protein engineering